Instrument Inactif

Gouvernance Immunoprecise Antibodies Ltd Other OTC

CA87588T1030

Produits pharmaceutiques

Comité Exécutif: Immunoprecise Antibodies Ltd

Dirigeant

Fonctions occupéesDepuis

Jennifer Bath

Chief Executive Officer	21/02/2018
President	21/02/2018

Lori Anderson

Sales & Marketing

01/12/2024

Hyfte Van

Chief Tech/Sci/R&D Officer

Richard Areglado

62 ans

Director of Finance/CFO

20/10/2025

Composition du Conseil d'Administration: Immunoprecise Antibodies Ltd

Administrateur

ComitésDepuis

Dirk Witters

Audit Committee
Compensation Committee Chair
Governance Committee Chair
Nominating Committee Chair

Jonathan Lieber

56 ans

Compensation Committee
Governance Committee	01/07/2019
Nominating Committee	01/07/2019
Audit Committee Chair
Audit Committee	01/07/2019

Jennifer Bath

Director/Board Member

24/05/2018

Anciens Dirigeants et Administrateurs: Immunoprecise Antibodies Ltd

Insider

Fonctions occupées

DepuisJusqu'au

Joseph Scheffler

Director of Finance/CFO	24/02/2025	20/10/2025
Public Communications Contact	24/02/2025	20/10/2025

Kamil Isaev

Director/Board Member	24/02/2025	09/10/2025
Independent Dir/Board Member	24/02/2025	09/10/2025

Ilse Roodink

Chief Tech/Sci/R&D Officer

01/07/2021

06/08/2025

Chris Buyse

Director/Board Member	05/09/2023	24/02/2025
Independent Dir/Board Member	05/09/2023	24/02/2025

Kristin Taylor

Director of Finance/CFO

29/09/2023

16/01/2025

Robert Burke

Director/Board Member	01/12/2017	09/11/2023
Independent Dir/Board Member	01/12/2017	09/11/2023

James Kuo

Chairman	01/12/2016	09/11/2023
Independent Dir/Board Member	01/12/2016	09/11/2023

Brad McConn

Director of Finance/CFO	05/08/2022	29/09/2023
Corporate Officer/Principal	01/01/2022	05/08/2022

Barry Springer

Director/Board Member	05/09/2023	-
Independent Dir/Board Member	05/09/2023	-

Gregory Smith

Director/Board Member	01/09/2016	05/09/2023
Independent Dir/Board Member	01/09/2016	05/09/2023

Carla Dahl

Sales & Marketing

04/08/2021

30/04/2023

Anna K. Pettersson

Director/Board Member

30/11/2021

13/12/2022

Lisa Helbling

Director of Finance/CFO	14/01/2019	05/08/2022
Director/Board Member	01/12/2022	09/11/2023

Stefan Lang

Corporate Officer/Principal

01/10/2019

28/04/2022

Brian Lundstrom

Director/Board Member

01/10/2019

30/11/2021

Gianpaolo Andreola

Director/Board Member	21/11/2018	10/11/2021
Independent Dir/Board Member	20/11/2018	10/11/2021

Yasmina Noubia Abdiche

Chief Tech/Sci/R&D Officer

01/04/2020

01/07/2021

Robert Beecroft

Director/Board Member	01/01/1989	22/06/2020
Chief Executive Officer	20/11/2017	21/02/2018
Chief Tech/Sci/R&D Officer	01/01/1989	24/05/2018
Founder	01/01/1989	22/06/2020

Jason Orloske

Chief Operating Officer

26/12/2018

30/11/2019

Andy Nixon

Director/Board Member

11/04/2019

28/08/2019

Natasha Tsai

Director of Finance/CFO

25/11/2016

14/01/2019

David Orton

Chief Operating Officer

29/03/2017

01/09/2018

Guy Champagne

Director/Board Member

01/12/2016

20/08/2018

Chip Wheelock

Chief Tech/Sci/R&D Officer

24/05/2018

Thomas D'Orazio

Director/Board Member	28/08/2016	20/11/2017
Chief Executive Officer	28/08/2016	20/11/2017
President	28/08/2016	20/11/2017

Lauren Smith

Sales & Marketing

03/04/2017

Robin Gamley

Public Communications Contact

01/03/2017

Mark Wayne

Director/Board Member	01/01/2007	01/01/2016
President	01/01/2007	01/01/2016

Deanna Dryhurst

Chief Tech/Sci/R&D Officer

01/01/2010

Barry Duplantis

Corporate Officer/Principal

Dawn Wattie

Corporate Secretary

Mitchell Levine

Director/Board Member	-	27/11/2023
Chairman	27/11/2023	-

Kevin Wong

President

Shuji Sato

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	8
Femme	2

Dont comité exécutif

Homme	3
Femme	1

Dont Administrateurs

Homme	3
Femme	0

MindWalk Holdings Corp., anciennement ImmunoPrecise Antibodies Ltd., est une entreprise spécialisée dans l'IA bio-native qui révolutionne la découverte et le développement de médicaments. S'appuyant sur la technologie brevetée HYFT et la plateforme LensAI, la société unifie les séquences, les structures, les fonctions et la littérature en un langage informatique unique et boucle la boucle grâce à un laboratoire de recherche intégré et complet. La plateforme prend en charge la cartographie rapide des épitopes, la conception moléculaire de novo, l'exploration in silico de vaccins et l'analyse des produits biologiques à l'échelle de la population, ce qui permet de transformer rapidement les connaissances en candidats validés.

Employés

Secteur

Produits pharmaceutiques

Plus d'informations sur la société